Company webinar

Immuron (ASX:IMC)

Watch our webinar with Immuron, featuring CEO Steven Lydeamore. An interview followed by live Q&A with the audience.

Date
December 8, 2026
Time
10:00 AM AEDT
Where
Online
Entry
Free
Steven Lydeamore
Steven Lydeamore
CEO, Immuron (ASX:IMC)

About the company

Immuron Limited (ASX:IMC | NASDAQ:IMRN) is a biopharmaceutical company redefining how we treat and prevent gut-mediated and infectious diseases. Using targeted, orally delivered antibodies, Immuron offers scalable, clinically backed solutions for global health challenges — starting with one of the most common travel-related illnesses, traveller's diarrhea

Key topics

  • Platform technology
  • Travelan
  • Financial performance
  • Plans for growth
  • Pipeline value

Watch the recording

More webinars

All webinars →

Go beyond the presentation

Management tells one side of the story. Sharewise clients get independent research and Advisor access across ASX, US and global markets.

Explore our services →